What are the treatment options for vaginal dryness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Vaginal Dryness

Water-based lubricants and moisturizers should be the first-line treatment for vaginal dryness, with vaginal estrogen reserved for those who do not respond adequately to non-hormonal options. 1

First-Line Treatment: Non-Hormonal Options

Vaginal Moisturizers

  • Apply 2-3 times weekly for ongoing relief 1
  • Work by hydrating vaginal tissues and maintaining moisture between applications
  • Examples include Replens and Sylk 1
  • Provide longer-lasting relief than lubricants, addressing day-to-day comfort

Lubricants for Sexual Activity

  • Use during all sexual activity 1
  • Water-based lubricants are generally safe and effective 2
  • Silicone-based products may last longer than water-based or glycerin-based products 2
  • Choose products with physiological pH and osmolality to minimize irritation 1, 3

A recent randomized trial demonstrated that water-based lubricants formulated to meet WHO guidelines for osmolality and pH significantly improved sexual function and reduced pain during intercourse 3.

Second-Line Treatment: Hormonal Options

Vaginal Estrogen

  • Consider for women who don't respond adequately to non-hormonal treatments 2, 1
  • Effective for treating vaginal dryness, itching, discomfort, and painful intercourse 2
  • Available as creams, rings, or tablets 2
  • For patients with estrogen-positive breast cancer history, estriol formulations are preferred due to lower systemic absorption 1

Ospemifene (Osphena)

  • Oral selective estrogen receptor modulator (SERM) approved for moderate to severe dyspareunia and vaginal dryness due to menopause 4
  • Take one 60 mg tablet with food once daily 4
  • Contraindicated in women with:
    • Undiagnosed abnormal genital bleeding
    • Known or suspected estrogen-dependent neoplasia
    • Active DVT, pulmonary embolism, or history of these conditions
    • Active arterial thromboembolic disease or history of these conditions 4
  • Not recommended for women with breast cancer 1, 4

Treatment Algorithm Based on Patient Characteristics

For Most Women with Vaginal Dryness:

  1. Start with non-hormonal moisturizers (2-3 times weekly) and lubricants during sexual activity 2, 1
  2. If inadequate response after 4-8 weeks, consider vaginal estrogen therapy 2, 1

For Women with History of Estrogen-Positive Breast Cancer:

  1. Non-hormonal moisturizers and lubricants are strongly preferred first-line options 1
  2. If non-hormonal options fail, consider intravaginal estriol (lowest systemic absorption) only after careful discussion of risks/benefits 1
  3. Avoid ospemifene due to estrogen agonist effects 4

For Women with Severe Symptoms and No Contraindications:

  1. Try non-hormonal options first
  2. If inadequate response, vaginal estrogen or ospemifene may be considered 4

Additional Supportive Measures

Pelvic Floor Muscle Training

  • May improve sexual pain, arousal, lubrication, orgasm, and satisfaction 2
  • Particularly helpful for women with concurrent pelvic floor dysfunction

Vaginal Dilators

  • Consider for vaginismus, sexual aversion disorder, vaginal scarring, or vaginal stenosis 2
  • Limited evidence for effectiveness but recommended in guidelines 2

Monitoring and Follow-up

  • Reassess treatment effectiveness every 3-6 months 1
  • For women using vaginal estrogen with intact uterus, monitor for abnormal vaginal bleeding 1
  • For women on ospemifene, use for shortest duration consistent with treatment goals due to potential risks 4

Important Caveats

  • Avoid products with potentially harmful ingredients that can cause irritation 5, 6
  • Women should choose products that are most similar to natural vaginal secretions in terms of pH and osmolality 5, 6
  • The evidence base for interventions to treat female sexual dysfunction is generally weak, highlighting the need for more high-quality studies 2
  • Vaginal dryness is often underreported and undertreated despite affecting over 50% of postmenopausal women 5

References

Guideline

Management of Vaginal Atrophy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Vaginal lubricants and moisturizers: a review into use, efficacy, and safety.

Climacteric : the journal of the International Menopause Society, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.